UBS Group AG

Position in LIMN — Liminatus Pharma, Inc.

CIK 1610520 ZURICH, V8

Position in LIMN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,840

-$7,546 QoQ

Shares Held

4,842

-13.5% QoQ

Ownership

0.360%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. LIMN ranks #501 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30 LIMNW	—	4,507	0.0%	Shares	Defined	2026-08-13
2026-06-30	$1,840	16,730	-69.3%	Shares	Defined	2026-08-13
2026-03-31 LIMNW	—	4,507	+7.0%	Shares	Defined	2026-05-05
2026-03-31	$9,386	54,578	+181.4%	Shares	Defined	2026-05-05
2025-12-31 LIMNW	—	4,212	+1352.4%	Shares	Defined	2026-01-29
2025-12-31	$11,830	19,395	-52.1%	Shares	Defined	2026-01-29
2025-09-30 LIMNW	—	290	-85.6%	Shares	Defined	2025-11-13
2025-09-30	$67,677	40,526	+28.7%	Shares	Defined	2025-11-13
2025-06-30 LIMNW	—	2,020	—	Shares	Defined	2025-08-14
2025-06-30	$351,068	31,486	—	Shares	Defined	2025-08-14
No filing history on record for this holder in this stock.